Medsafe Logo
Hide menus
Show menus


Revised: 2 September 2015

Medicines Assessment Advisory Committee

Terms of reference

The Medicines Assessment Advisory Committee (MAAC) is a technical advisory committee established under section 8 of the Medicines Act 1981 to advise the Minister of Health on the risk-benefit profile of new medicines.

The terms of reference of the MAAC are as follows:


The Medicines Assessment Advisory Committee (MAAC) is scheduled to meet three times a year (usually in March, June and September). Secretarial support is provided by Medsafe.

The 102nd meeting of the MAAC is scheduled to take place on Tuesday 10 September 2015.

The agenda for the 102nd meeting is now available


The Medicines Assessment Advisory Committee (MAAC) comprises up to 12 members with any of the following:

Members are appointed for a three year term, which may only be renewed once. Medsafe is always willing to hear from suitably experienced candidates who are willing to be considered for appointment by the Minister of Health, even during a period when specific appointments are not being sought:

Joining the Committee

0 1 2 4 5 6 7 9 [ /